|
SEPSECS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.95909996295541E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.28969995688766E-09 |
| Normal-vs-Stage2 |
1.78700000019738E-07 |
| Normal-vs-Stage3 |
8.90831852728979E-12 |
| Normal-vs-Stage4 |
2.33310004649212E-09 |
| Stage1-vs-Stage2 |
9.041800E-01 |
| Stage1-vs-Stage3 |
1.261010E-01 |
| Stage1-vs-Stage4 |
1.004250E-01 |
| Stage2-vs-Stage3 |
2.794600E-01 |
| Stage2-vs-Stage4 |
1.891840E-01 |
| Stage3-vs-Stage4 |
7.027600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.00039984576961E-10 |
| Normal-vs-AfricanAmerican |
6.571300E-04 |
| Normal-vs-Asian |
1.54810000041472E-07 |
| Caucasian-vs-AfricanAmerican |
2.158000E-01 |
| Caucasian-vs-Asian |
3.589600E-01 |
| AfricanAmerican-vs-Asian |
6.339600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.15310016879766E-10 |
| Normal-vs-Female |
3.5327996084078E-10 |
| Male-vs-Female |
2.306400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.00489999549569E-09 |
| Normal-vs-Age(41-60Yrs) |
7.30050020436579E-10 |
| Normal-vs-Age(61-80Yrs) |
5.5624005401711E-10 |
| Normal-vs-Age(81-100Yrs) |
9.517200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.556000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.218600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.510200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.983400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.614200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.686200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.43100000000874E-05 |
| Classical-VS-Follicular |
1.141610E-01 |
| Classical-VS-Other |
9.975200E-01 |
| Classical-VS-Normal |
4.65429994545019E-09 |
| Tall-VS-Follicular |
1.9990099999978E-05 |
| Tall-VS-Other |
5.983600E-02 |
| Tall-VS-Normal |
2.17226236998158E-12 |
| Follicular-VS-Other |
6.399200E-01 |
| Follicular-VS-Normal |
5.3179000003567E-07 |
| Other-VS-Normal |
1.271600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.2788437803456E-12 |
| Normal-vs-N1 |
2.71360000025922E-08 |
| N0-vs-N1 |
4.098400E-01 |
|
|
